Scientific Program
Time: July 22-24, 2023
Venue: Catalonia Barcelona Plaza, Spain
Keynote Forum |
|
Time: 09:10-12:10, July 22, 2023 (Saturday); Place: Catalonia Barcelona Plaza, Spain |
|
|
|
Moderator |
To Be Confirmed Soon |
|
|
09:10-09:15 |
Moderator's Introduction |
09:15-09:40 |
Title: The Origin of Bladder Cancer Dr. Bogdan Czerniak, Professor, The University of Texas M. D. Anderson Cancer Center, USA |
09:40-10:05 |
Title: TBD |
10:05-10:30 |
Title: TBD |
10:30-10:55 |
Title: TBD |
10:55-1120 |
Title: TBD |
11:20-11:45 |
Title: TBD |
11:45-12:10 |
Title: Prospects for Targeted Protein Degraders in the Fight Against Aggressive Cancer |
WCC 01: Cancer Cell Biology & Genetics |
|
Time: 14:00-18:20, July 22, 2023 (Saturday); Place: Catalonia Barcelona Plaza, Spain |
|
|
|
Chair |
Dr. Rony Seger, Professor, Weizmann Institute of Science, Israel |
Co-Chair |
Dr. Xin Wang, Associate Professor, The Chinese University of Hong Kong, Hong Kong of China |
|
|
14:00-14:05 |
Chair's Introduction |
14:05-14:25 |
Keynote Speech Dr. Rony Seger, Professor, Weizmann Institute of Science, Israel |
14:25-14:45 |
Title: TBD |
14:45-15:05 |
Title: The Molecular Signature of Metastasis in the Early Stages of Clear Cell Renal Cell Carcinoma |
15:05-15:25 |
Title: The Ubiquitin-Independent Protein Degradation Pathway In Cancer Progression |
15:25-15:45 |
Title: Elucidating Osteoclast-Breast Tumor Hybrids Cell Fusion Mechanisms for Bone Metastatic Disease Progression |
15:45-16:00 |
Coffee Break |
16:00-16:20 |
Title: Dissecting the Molecular Heterogeneity of Young-onset Colorectal Cancer |
16:20-16:40 |
Title: Human RNASET2: A Highly Pleiotropic Tumor Suppressor Gene Involved in Establishing a Complex Crosstalk between Cancer Cells and the Tumor Microenvironment |
16:40-17:00 |
Title: Intricating Membrane Transport and Metabolism with Intracellular pH Regulation. Insights into Mechanisms, Robustness, And Functional Redundancy Dr. Laurent Counillon, Professor, Université Nice-Sophia Antipolis, France |
17:00-17:20 |
Title: Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis |
17:20-17:40 |
Title: The Role of Genomic Structural Variants in Prognosis and Treatment of Cancer Dr. James R. Broach, Distinguished Professor and Chair, Penn State College of Medicine, USA |
17:40-18:00 |
Title: The p 207 S LysRS–Ap4A–Hint-1–MITF Pathway in Health and Diseases Dr. Ehud Razin, Professor, Hebrew University Hadassah Medical School, Israel |
18:00-18:20 |
Speech Opportunity Available |
WCC 02: Anti-Cancer Drug Discovery and Development |
|
Time: 08:30-12:30, July 23, 2023 (Sunday); Place: Catalonia Barcelona Plaza, Spain |
|
|
|
Chair |
Dr. Pran K. Datta, Professor, University of Alabama at Birmingham, USA |
Co-Chair |
Dr. Lixin Rui, Associate Professor, University of Wisconsin-Madison, USA |
|
|
08:30-08:35 |
Chair's Introduction |
08:35-08:55 |
Title: TBD Dr. Zvi Naor, Professor, Tel Aviv University, Israel |
08:55-09:15 |
Title: Ablation rate and Thyroglobulin Decrease after Low-dose 131-I in Differentiated Thyroid Carcinoma Post-Total Thyroidectomy at Vietnam National Cancer Hospital Dr. Duong Duc Binh, National Cancer Hospital (K hospital), Hanoi, Vietnam |
09:15-09:35 |
Title: Anticancer Activity of Selected Plants of Israel and Palestine |
09:35-09:55 |
Title: ME-503 for Immune-Oncology Treatment: A Novel Mode of Action Dr. Hans Lentzen, Managing Director, MELEMA Pharma GmbH, Germany |
09:55-10:15 |
Title: Targeting Ibrutinib Resistance in B Cell Lymphoma Dr. Lixin Rui, Associate Professor, University of Wisconsin-Madison, USA |
10:15-10:30 |
Coffee Break |
10:30-10:50 |
Title: Molecular Mechanisms of Colon Tumorigenesis and Chemoresistance Dr. Pran K. Datta, Professor, University of Alabama at Birmingham, USA |
10:50-11:10 |
Title: Chemo-Immunotherapy of Nanomedicine and anti-PD-1 antibody for Reprogramming Tumor Microenvironment to Overcome anti-PD-1 antibody-Resistance |
11:10-11:30 |
Title: Finding a Potential Prognostic Biomarker with Analyzing A Serum Soluble CD26/DPP4 Titer Variation from Baseline in Cancer Treatment on Patients with CD26+Tumor in Phase I and Phase I/II Clinical Trials by a Humanized anti-CD26 Monoclonal Antibody Therapy Dr. Yutaro Kaneko, CEO, Juntendo University, Tokyo, Japan |
11:30-11:50 |
Title: TBD Dr. Dorit Avni, Sphingolipids, MIGAL - Galilee Research Institute, Israel |
11:50-12:10 |
Title: Anti Cancer : Rational Design by Trojan Horse Strategy Dr. Nohad Al Omar, College of Pharmacy, Knowledge university, Iraq |
12:10-12:30 |
Speech Opportunity Available |
WCC 03: Cancer Therapy & Treatments-Part I |
|
Time: 08:30-12:10, July 23, 2023 (Sunday); Place: Catalonia Barcelona Plaza, Spain |
|
|
|
Chair |
Dr. Hariprasad Vankayalapati, Chief Scientific Officer, Biolexis Therapeutics, Inc., USA |
Co-Chair |
Dr. Zhirui Wang, Associate Professor, University of Colorado Anschutz Medical Campus, USA |
|
|
08:30-08:35 |
Chair's Introduction |
08:35-08:55 |
Title: Haemorrhagic Small Bowel Melanoma Metastasis: A Clinical Rarity Dr. Alexandros Zoumpos, Physician, Helios Klinik Herzberg/Osterode, Germany |
08:55-09:15 |
Title: Measurement of Small Blood and Lymphatic Vessels in the Brain Using Novel MRI Techniques |
09:15-09:35 |
Title: Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer Dr. Serena Sestini, Regional Melanoma Referral Center, USA |
09:35-09:55 |
Title: Manufacturing Control of Investigational CAR-T- cell products: Standards, Guidelines and Opportunities Dr. Devanjan Sikder, Associate Director, Memorial Sloan-Kettering Cancer Center, USA |
09:55-10:15 |
Title: CCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma |
10:15-10:30 |
Coffee Break |
10:30-10:50 |
Title: Labyrinthin Moves from Bench-To-Clinic as Both Neo- And Pan-Adenocarcinoma Target |
10:50-11:10 |
Title: Mechanisms underlying Heterogeneous Outcome of Immune Checkpoint Inhibitors in Mouse HNSCC Models Dr. Jing H. Wang, Professor, UPMC Hillman Cancer Center, University of Pittsburgh, USA |
11:10-11:30 |
Title: AI/ML Driven Discovery and Development of Cancer Immunotherapeutics Through Small Molecules and Targeted Protein Degraders |
11:30-11:50 |
Title: A Novel Genetically Engineered Blood System for Cancer Therapy Dr. James Che-Kun Shen, Chair Professor, Taipei Medical University, Taipei, Taiwan |
11:50-12:10 |
Speech Opportunity Available |
WCC 04: Clinical Oncology |
|
Time: 14:00-18:20, July 23, 2023 (Sunday); Place: Catalonia Barcelona Plaza, Spain |
|
|
|
Chair |
Dr. Junichi Arita, Professor, Department of Gastroenterological Surgery, Akita University, Japan |
Co-Chair |
Dr. Andrew H Rodgers, Director of Regulatory & Analytical Affairs, Dekk Tec. Inc., USA |
|
|
14:00-14:05 |
Chair's Introduction |
14:05-14:25 |
Title: Female Students’ Knowledge, Beliefs, Attitude and Practice of Breast Self-Examination in a University in the Western Cape Ms. Mavis Bobie Ansah, Oncology Nurse Specialist, Komfo Anokye Teaching Hospital, Ghana |
14:25-14:45 |
Title: Hepatic Resections an Liver Transplantation: Signaling Pathways Involved in Protection Against Hepatic Ischemia-Reperfusion Damage and Liver Regeneration Failure: role of liver-adipose tissue axis Dr. Carmen Peralta, Senior Group Leader, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Spain |
14:45-15:05 |
Title: Repeat Resection of Neuroendocrine Liver Metastases and Possibility of Cure |
15:05-15:25 |
Title: Systemic Chemotherapy for Soft Tissue Sarcoma Rather than Liver, Pancreatic And Biliary Tract Cancer Dr. Hiroyuki Narahara, Director of Clinical Research Center, Hyogo Prefectural Nishinomiya Hospital, Japan |
15:25-15:45 |
Title: ROS Homeostasis and Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma Dr. Eunyoung Tak, Associate Professor, University of Ulsan College of Medicine, South Korea |
15:45-16:00 |
Coffee Break |
16:00-16:20 |
Title: Impact of Viral Burden and Trajectory of Hepatocellular Carcinoma in Armenia Dr. Hasmik Ghazinyan, Nork Clinical Hospital of Infectious Diseases, Yerevan , Armenia |
16:20-16:40 |
Title: Reconstructive Surgery of the Upper Lip after Combined Resection of the Upper Lip and Buccal Mucosa for Oral Cancer Dr. Kazuhide Matsunaga, Associate Professor, Osaka University, Japan |
16:40-17:00 |
Title: Up-date: Use of 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) as Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Involving the CNS Dr. Andrew H Rodgers, Director of Regulatory & Analytical Affairs, Dekk Tec. Inc., USA |
17:00-17:20 |
Title: Advanced Oral Cancers Surgical Management Dr. Harsh Dhar, Consultant Head Neck and Skull Base Surgeon, Medica Superspeciality Hospitals & Cancer Centre, India |
17:20-17:40 |
Title: Rare Cutaneous Tumors: A Case Report of Angiosarcoma and Primary Cutaneous Lymphoma Dr. Typhannie Coelho Borges Silva, Tocantinense University Center Presidente Antônio Carlos - UNITPAC, Brazil |
17:40-18:00 |
Title: Updates in Thyroid Nodules Management |
18:00-18:20 |
Speech Opportunity Available |
WCC 05: Cancer Therapy & Treatments-Part II |
|
Time: 08:30-12:10, July 24, 2023 (Monday); Place: Catalonia Barcelona Plaza, Spain |
|
|
|
Chair |
Dr. Thomas Böldicke, Senior Scientist, Department Structure and Function of Proteins, Helmholtz Centre for Infection Research, Germany |
Co-Chair |
Dr. Jerome H. Check, Professor, Cooper Medical School of Rowan University, USA |
|
|
08:30-08:35 |
Chair's Introduction |
08:35-08:55 |
Title: Treatment with Progesterone Antagonists May Be the Key to Converting Many End-Stage Cancers Into a Chronic Disease With Low Morbidity |
08:55-09:15 |
Title: Targeting Microtubule Stabilization to Reduce Breast Cancer Metastasis |
09:15-09:35 |
Title: Absorbed Dose and Its Determination in Hadrontherapy Dr. Grazia Gambarini, Associate Professor, Department of Physics, Università degli Studi di Milano, National Institute of Nuclear Physics (INFN), Section of Milano, Italy |
09:35-09:55 |
Title: Therapeutic Inhibitors of Progression of Neuroblastoma Cells Dr. Nada Al-Hasawi, Kuwait University, Kuwait |
09:55-10:15 |
Title: Triple Negative Breast Cancer Therapy: A Novel Approach Dr. Antonio Ponzetto, Retired Professor of Gastroenterology University of Torino, Torino, Italy |
10:15-10:30 |
Coffee Break |
10:30-10:50 |
Title: Mature TERATOMA in the Right Ventricle Dr. Fekede D Agwar, Addis Ababa University, Ethiopia |
10:50-11:10 |
Title: The Role of SNAIL 1 and SNAIL 2 Transcriptional Factors in the Development Of Ovarian Cancer Cells’ Chemoresistance in the Context of Their Metastatic Potential |
11:10-11:30 |
Title: Pigmented Lesion on the Face: Which is The Chance of Being Melanoma Using Reflectance Confocal Microscopy Features Dr. Fernanda Mendes, Physician, AC Camargo Cancer Cente, Brazil |
11:30-11:50 |
Title: Therapeutic Potential of Intrabodies Against Neoantigens: Current Status And Future Directions |
11:50-12:10 |
Speech Opportunity Available |
WCC 06: Oncology Nursing and Prevention |
|
Time: 14:00-18:00, July 24, 2023 (Monday); Place: Catalonia Barcelona Plaza, Spain |
|
|
|
Chair |
Dr. Jacqueline T. Norrell, Director, Rutgers Cancer Institute, USA |
|
|
14:00-14:05 |
Chair's Introduction |
14:05-14:25 |
Title: Complexity of Care and Nursing Management of Toxicities in Cancer Patients Receiving Immunotherapy Including Cellular Therapy Treatments: The New Phenotype |
14:25-14:45 |
Title: Improving Medication Adherence and Symptom Management in Patients with Cancer Dr. Carla Schaefer, Associate Chief Nursing Officer, The State University of New Jersey, USA |
14:45-15:05 |
Title: Innovation in Ambulatory Cancer Care-Memorial Sloan Kettering Cancer Center |
15:05-15:25 |
Title: Outpatient Palliative Care for Advance Cancer Patients: Implementation of a Day Hospital Dr. Laura Thery, Consultant, Institut Curie, France |
15:25-15:45 |
Title: Coping Strategies and Their Impact on Emotional Distress and Fatigue Among Breast Cancer Survivors Dr. Inbar Levkovich, Associate Professor, Oranim Academic College of Education, Israel |
15:45-16:00 |
Coffee Break |
16:00-16:20 |
Title: Cognitive deficits and psychopathological symptoms among children with medulloblastoma Dr. Annamária Szentes, Clinical Child Psychologist, 2nd Department of Paediatrics, Semmelweis University, Hungary |
16:20-16:40 |
Title: Epidemiology of Breast Cancer In Women Based On Diagnosis Data From Oncologists And Senologists In Algeria Dr. A Boudjella, Blida 1 University, Algeria |
16:40-17:00 |
Title: Combining the American Thyroid Association's Ultrasound Classification with Cytological Subcategorization Improves the Assessment of Malignancy Risk in Indeterminate Thyroid Nodules Dr. Aline Machado Larcher de Almeida, School of Medicine of Federal University of Rio de Janeiro, Brazil |
17:00-17:20 |
Title: Production and Prebiotic Properties of Oligofructans from Sugarcane Juice Fermentation by Bacillus subtilis TISTR 001 |
17:20-17:40 |
Title: The Impact of Social Vulnerability on Time to Treatment Disparities Among Insured Adult Patients with Metastatic Cancers |
17:40-18:00 |
Speech Opportunity Available |
Video |
|
1 |
Title: Predicting Response to Immunotherapy in Head and Neck Cancer |
2 |
Title: TBD |
3 |
Title: Molecular Iodine in Chemoresistant Cancers Dr. Carmen Aceves, Universidad Nacional Autómona de México, México |
4 |
Title: TRIM32 Promotes Radioresistance by Disrupting TC45-STAT3 Interaction in Triple-Negative Breast Cancer Dr. Jianming Tang, Zhejiang Provincial People' s Hospital, People' s Hospital of Hangzhou Medical College, China |
5 |
Title: TBD |
6 |
Title: Assessment of Extremely Low Frequency Electromagnetic Field Exposure In Children In Residential Settings through Machine Learning Dr. Gabriella Tognola, Cnr-Istituto di Elettronica e di Ingegneria dell’Informazione e delle Telecomunicazioni (CNR-IEIIT) Milano, Italy |
7 |
Title: Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients - Full Text View - ClinicalTrials.gov Dr. Aditya Shreenivas, Assistant Professor, Medical College of Wisconsin, USA |
9 |
Title: Repeat periods of electrical stimulation prolong the modulation of the micturition reflex in the rat Dr. Chonghe Jiang, The Sixth Affiliated Hospital of Guangzhou Medical University, China |
10 |
Title: TBD |
Contact Us
Add: Life Science Innovation Center BLD 3-2, 43 Torch Road,
High Tech Park, Dalian, LN 116023, China
© 2003-2023 All rights reserved by BIT Congress